Goldman Sachs’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04K | Buy |
+1,100
| New | +$3.04K | ﹤0.01% | 5098 |
|
|
2025
Q1 | – | Sell |
-1,459
| Closed | -$20.1K | – | 5101 |
|
|
2024
Q4 | $20.1K | Buy |
+1,459
| New | +$20.1K | ﹤0.01% | 4905 |
|
|
2022
Q3 | – | Sell |
-1,053
| Closed | -$1.26M | – | 5497 |
|
|
2022
Q2 | $1.26M | Sell |
1,053
-6
| -0.6% | -$7.16K | ﹤0.01% | 3790 |
|
|
2022
Q1 | $1.26M | Buy |
1,059
+309
| +41% | +$367K | ﹤0.01% | 3948 |
|
|
2021
Q4 | $883K | Buy |
+750
| New | +$883K | ﹤0.01% | 4127 |
|